A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis
Status:
Unknown status
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the safety and effectiveness of sirolimus treatment
for people with systemic sclerosis.
The investigators perform a multi-centre, double-blind pilot trial with sirolimus in SSc.The
investigators evaluate the effectiveness and safeness of sirolimus for Systemic Sclerosis by
randomized controlled study (sirolimus 2mg/d (N = 36) versus placebo group (N = 36)).